{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:16:34Z","timestamp":1770272194792,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Moscow Health Department","award":["AAAA-A18-118021590195-4"],"award-info":[{"award-number":["AAAA-A18-118021590195-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12325-021-01983-5","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T10:02:26Z","timestamp":1636624946000},"page":"430-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases?"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-203X","authenticated-orcid":false,"given":"Sergey","family":"Batskikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6816-3058","authenticated-orcid":false,"given":"Sergey","family":"Morozov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0344-8375","authenticated-orcid":false,"given":"Elena","family":"Vinnitskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2195-9643","authenticated-orcid":false,"given":"Evgeniya","family":"Sbikina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-1513","authenticated-orcid":false,"given":"Zanna","family":"Borunova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-7579","authenticated-orcid":false,"given":"Alexey","family":"Dorofeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-812X","authenticated-orcid":false,"given":"Yulia","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4581-7052","authenticated-orcid":false,"given":"Kirill","family":"Saliev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1851-7441","authenticated-orcid":false,"given":"Dmitry","family":"Kostyushev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-0739","authenticated-orcid":false,"given":"Sergey","family":"Brezgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2335-6582","authenticated-orcid":false,"given":"Anastasiya","family":"Kostyusheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-9293","authenticated-orcid":false,"given":"Vladimir","family":"Chulanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"issue":"7","key":"1983_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/MEG.0b013e328353750c","volume":"24","author":"C Della Corte","year":"2012","unstructured":"Della Corte C, Sartorelli MR, Sindoni CD, et al. Autoimmune hepatitis in children: an overview of the disease focusing on current therapies. Eur J Gastroenterol Hepatol. 2012;24(7):739\u201346. https:\/\/doi.org\/10.1097\/MEG.0b013e328353750c.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"1983_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.autrev.2011.06.003","volume":"10","author":"T Santodomingo-Garzon","year":"2011","unstructured":"Santodomingo-Garzon T, Swain MG. Role of NKT cells in autoimmune liver disease. Autoimmun Rev. 2011;10(12):793\u2013800. https:\/\/doi.org\/10.1016\/j.autrev.2011.06.003.","journal-title":"Autoimmun Rev"},{"key":"1983_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","volume":"66","author":"GJ Webb","year":"2016","unstructured":"Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun. 2016;66:25\u201339. https:\/\/doi.org\/10.1016\/j.jaut.2015.08.016.","journal-title":"J Autoimmun"},{"key":"1983_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaut.2015.07.004","volume":"64","author":"GJ Webb","year":"2015","unstructured":"Webb GJ, Siminovitch KA, Hirschfield GM. The immunogenetics of primary biliary cirrhosis: a comprehensive review. J Autoimmun. 2015;64:42\u201352. https:\/\/doi.org\/10.1016\/j.jaut.2015.07.004.","journal-title":"J Autoimmun"},{"issue":"1","key":"1983_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jhep.2014.09.010","volume":"62","author":"JK Dyson","year":"2015","unstructured":"Dyson JK, Webb G, Hirschfield GM, et al. Unmet clinical need in autoimmune liver diseases. J Hepatol. 2015;62(1):208\u201318. https:\/\/doi.org\/10.1016\/j.jhep.2014.09.010.","journal-title":"J Hepatol"},{"issue":"1","key":"1983_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1568-9972(03)00053-3","volume":"3","author":"S Vento","year":"2004","unstructured":"Vento S, Cainelli F. Is there a role for viruses in triggering autoimmune hepatitis? Autoimmun Rev. 2004;3(1):61\u20139. https:\/\/doi.org\/10.1016\/S1568-9972(03)00053-3.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"1983_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/v11080762","volume":"11","author":"MK Smatti","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762. https:\/\/doi.org\/10.3390\/v11080762 (Published 2019 Aug 19).","journal-title":"Viruses"},{"issue":"2","key":"1983_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","volume":"71","author":"G Raimondo","year":"2019","unstructured":"Raimondo G, Locarnini S, Pollicino T, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397\u2013408. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.034.","journal-title":"J Hepatol"},{"issue":"11","key":"1983_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","volume":"18","author":"GC Fanning","year":"2019","unstructured":"Fanning GC, Zoulim F, Hou J, Bertoletti A. Therapeutic strategies for hepatitis B virus infection: towards a cure [published correction appears in Nat Rev Drug Discov. 2020 Jan 8]. Nat Rev Drug Discov. 2019;18(11):827\u201344. https:\/\/doi.org\/10.1038\/s41573-019-0037-0.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1983_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41573-019-0057-9","volume":"19","author":"GC Fanning","year":"2020","unstructured":"Fanning GC, Zoulim F, Hou J, Bertoletti A. Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cure. Nat Rev Drug Discov. 2020;19(4):291. https:\/\/doi.org\/10.1038\/s41573-019-0057-9.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1983_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1478-3231.2008.01851.x","volume":"29","author":"SP Georgiadou","year":"2009","unstructured":"Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int. 2009;29(3):434\u201342. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01851.x.","journal-title":"Liver Int"},{"issue":"6","key":"1983_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jmii.2019.04.009","volume":"53","author":"XX Chen","year":"2020","unstructured":"Chen XX, Xiang KH, Zhang HP, et al. Occult HBV infection in patients with autoimmune hepatitis: a virological and clinical study. J Microbiol Immunol Infect. 2020;53(6):946\u201354. https:\/\/doi.org\/10.1016\/j.jmii.2019.04.009.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"1983_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3748\/wjg.v21.i1.283","volume":"21","author":"BA Li","year":"2015","unstructured":"Li BA, Liu J, Hou J, et al. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations. World J Gastroenterol. 2015;21(1):283\u201391. https:\/\/doi.org\/10.3748\/wjg.v21.i1.283.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1983_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169\u201376. https:\/\/doi.org\/10.1002\/hep.22322.","journal-title":"Hepatology"},{"issue":"1","key":"1983_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145\u201372. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.022.","journal-title":"J Hepatol"},{"issue":"5","key":"1983_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ajg.2015.112","volume":"110","author":"KD Lindor","year":"2015","unstructured":"Lindor KD, Kowdley KV, Harrison ME, American College of Gastroenterology. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110(5):646\u201360. https:\/\/doi.org\/10.1038\/ajg.2015.112.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1983_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/hep.24257","volume":"54","author":"AS Lok","year":"2011","unstructured":"Lok AS, Everhart JE, Di Bisceglie AM, et al. Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 2011;54(2):434\u201342. https:\/\/doi.org\/10.1002\/hep.24257.","journal-title":"Hepatology"},{"key":"1983_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-1-62703-484-5_13","volume":"1030","author":"D Cai","year":"2013","unstructured":"Cai D, Nie H, Yan R, Guo JT, Block TM, Guo H. A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures. Methods Mol Biol. 2013;1030:151\u201361. https:\/\/doi.org\/10.1007\/978-1-62703-484-5_13.","journal-title":"Methods Mol Biol"},{"key":"1983_CR19","doi-asserted-by":"publisher","first-page":"9151525","DOI":"10.1155\/2021\/9151525","volume":"2021","author":"J Gazda","year":"2021","unstructured":"Gazda J, Drazilova S, Janicko M, Jarcuska P. The epidemiology of primary biliary cholangitis in European countries: a systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2021;2021:9151525. https:\/\/doi.org\/10.1155\/2021\/9151525 (Published 2021 Jun 19).","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"1983_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","volume":"34","author":"R Maya","year":"2008","unstructured":"Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol. 2008;34(1):85\u2013102. https:\/\/doi.org\/10.1007\/s12016-007-8013-6.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1983_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fimmu.2018.00163","volume":"9","author":"U Christen","year":"2018","unstructured":"Christen U, Hintermann E. Autoantibodies in autoimmune hepatitis: can epitopes tell us about the etiology of the disease? Front Immunol. 2018;9:163. https:\/\/doi.org\/10.3389\/fimmu.2018.00163 (Published 2018 Feb 16).","journal-title":"Front Immunol"},{"issue":"4","key":"1983_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5009\/gnl19261","volume":"14","author":"A Tanaka","year":"2020","unstructured":"Tanaka A. Autoimmune hepatitis: 2019 update. Gut Liver. 2020;14(4):430\u20138. https:\/\/doi.org\/10.5009\/gnl19261.","journal-title":"Gut Liver"},{"issue":"1","key":"1983_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/cei.13203","volume":"195","author":"U Christen","year":"2019","unstructured":"Christen U, Hintermann E. Pathogens and autoimmune hepatitis. Clin Exp Immunol. 2019;195(1):35\u201351. https:\/\/doi.org\/10.1111\/cei.13203.","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"1983_CR24","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/diagnostics11081418","volume":"11","author":"W Domerecka","year":"2021","unstructured":"Domerecka W, Kowalska-K\u0119pczy\u0144ska A, Michalak A, et al. Etiopathogenesis and diagnostic strategies in autoimmune hepatitis. Diagnostics. 2021;11(8):1418. https:\/\/doi.org\/10.3390\/diagnostics11081418 (Published 2021 Aug 5).","journal-title":"Diagnostics"},{"issue":"10","key":"1983_CR25","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/liv.15007","volume":"41","author":"TI Mehta","year":"2021","unstructured":"Mehta TI, Weissman S, Fung BM, Sotiriadis J, Lindor KD, Tabibian JH. Global incidence, prevalence and features of primary sclerosing cholangitis: a systematic review and meta-analysis. Liver Int. 2021;41(10):2418\u201326. https:\/\/doi.org\/10.1111\/liv.15007.","journal-title":"Liver Int"},{"key":"1983_CR26","unstructured":"On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2020: State report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Well-being, 2021. 256 p. https:\/\/www.rospotrebnadzor.ru\/bitrix\/redirect.php?event1=file&event2=download&event3=gd-seb_02.06-_s-podpisyu_.pdf&goto=\/upload\/iblock\/5fa\/gd-seb_02.06-_s-podpisyu_.pdf. Accessed 20 Sep 2021."},{"issue":"4","key":"1983_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/cld.883","volume":"15","author":"A Myint","year":"2020","unstructured":"Myint A, Tong MJ, Beaven SW. Reactivation of hepatitis B virus: a review of clinical guidelines. Clin Liver Dis. 2020;15(4):162\u20137. https:\/\/doi.org\/10.1002\/cld.883 (Published 2020 May 7).","journal-title":"Clin Liver Dis"},{"issue":"3","key":"1983_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7861\/clinmedicine.18-3-212","volume":"18","author":"A Koffas","year":"2018","unstructured":"Koffas A, Dolman GE, Kennedy PT. Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians. Clin Med. 2018;18(3):212\u20138. https:\/\/doi.org\/10.7861\/clinmedicine.18-3-212.","journal-title":"Clin Med"},{"issue":"151","key":"1983_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.31550\/1727-2378-2018-151-7-30-34","volume":"7","author":"SN Batskikh","year":"2018","unstructured":"Batskikh SN, Vinnitskaya EV, Sbikina ES, et al. Occult hepatitis B in patients with hepatic cirrhosis and primary biliary cholangitis. Doctor.Ru. 2018;7(151):30\u20134. https:\/\/doi.org\/10.31550\/1727-2378-2018-151-7-30-34.","journal-title":"Doctor.Ru"},{"issue":"6","key":"1983_CR30","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","volume":"152","author":"R Loomba","year":"2017","unstructured":"Loomba R, Liang TJ. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology. 2017;152(6):1297\u2013309. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.009.","journal-title":"Gastroenterology"},{"issue":"4","key":"1983_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MPG.0000000000002628","volume":"70","author":"G Indolfi","year":"2020","unstructured":"Indolfi G, Abdel-Hady M, Bansal S, et al. Management of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies. J Pediatr Gastroenterol Nutr. 2020;70(4):527\u201338. https:\/\/doi.org\/10.1097\/MPG.0000000000002628.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"1983_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021.","journal-title":"J Hepatol"},{"key":"1983_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31030","author":"M Cornberg","year":"2019","unstructured":"Cornberg M, Lok AS, Terrault NA, Zoulim F, 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference [published online ahead of print, 2019 Nov 12]. Hepatology. 2019. https:\/\/doi.org\/10.1002\/hep.31030.","journal-title":"Hepatology"},{"key":"1983_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.omtn.2020.03.005","volume":"20","author":"YC Yang","year":"2020","unstructured":"Yang YC, Chen YH, Kao JH, et al. Permanent inactivation of HBV genomes by CRISPR\/Cas9-mediated non-cleavage base editing. Mol Ther Nucleic Acids. 2020;20:480\u201390. https:\/\/doi.org\/10.1016\/j.omtn.2020.03.005.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1983_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/2049936120965027","author":"V Soriano","year":"2020","unstructured":"Soriano V, Barreiro P, Cachay E, Kottilil S, Fernandez-Montero JV, de Mendoza C. Advances in hepatitis B therapeutics. Ther Adv Infect Dis. 2020. https:\/\/doi.org\/10.1177\/2049936120965027 (Published 2020 Oct 15).","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"1983_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/mt.2016.1","volume":"24","author":"CM Lee","year":"2016","unstructured":"Lee CM, Cradick TJ, Fine EJ, Bao G. Nuclease target site selection for maximizing on-target activity and minimizing off-target effects in genome editing. Mol Ther. 2016;24(3):475\u201387. https:\/\/doi.org\/10.1038\/mt.2016.1.","journal-title":"Mol Ther"},{"issue":"4","key":"1983_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/genes9040207","volume":"9","author":"K Bloom","year":"2018","unstructured":"Bloom K, Maepa MB, Ely A, Arbuthnot P. Gene therapy for chronic HBV-can we eliminate cccDNA? Genes. 2018;9(4):207. https:\/\/doi.org\/10.3390\/genes9040207 (Published 2018 Apr 12).","journal-title":"Genes"},{"issue":"2","key":"1983_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hep.29082","volume":"66","author":"S Paul","year":"2017","unstructured":"Paul S, Dickstein A, Saxena A, et al. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a meta-analysis. Hepatology. 2017;66(2):379\u201388. https:\/\/doi.org\/10.1002\/hep.29082.","journal-title":"Hepatology"},{"issue":"4","key":"1983_CR39","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/hep.29357","volume":"66","author":"YH Huang","year":"2017","unstructured":"Huang YH, Lee SD. Is antibody to surface antigen associated with hepatitis B reactivation in patients with resolved hepatitis B? Hepatology. 2017;66(4):1353. https:\/\/doi.org\/10.1002\/hep.29357.","journal-title":"Hepatology"},{"issue":"5","key":"1983_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.nefro.2018.02.004","volume":"38","author":"C Meng","year":"2018","unstructured":"Meng C, Belino C, Pereira L, et al. Reactivation of Hepatitis B virus in kidney transplant recipients with previous clinically resolved infection: a single-center experience. Nefrologia. 2018;38(5):545\u201350. https:\/\/doi.org\/10.1016\/j.nefro.2018.02.004.","journal-title":"Nefrologia"},{"issue":"3","key":"1983_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcv.2012.07.015","volume":"55","author":"N Kanaan","year":"2012","unstructured":"Kanaan N, Kabamba B, Mar\u00e9chal C, et al. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection. J Clin Virol. 2012;55(3):233\u20138. https:\/\/doi.org\/10.1016\/j.jcv.2012.07.015.","journal-title":"J Clin Virol"},{"issue":"9","key":"1983_CR42","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbmt.2009.05.001","volume":"15","author":"SP Hammond","year":"2009","unstructured":"Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(9):1049\u201359. https:\/\/doi.org\/10.1016\/j.bbmt.2009.05.001.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01983-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T08:42:36Z","timestamp":1643359356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01983-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1983"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01983-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"29 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}